Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

Market Cap	41.16B
Revenue (ttm)	3.91B
Net Income (ttm)	1.53B
Shares Out	450.00M
EPS (ttm)	3.41
PE Ratio	26.82
Forward PE	23.05
Dividend	0.80 (0.89%)
Ex-Dividend Date	Jun 3, 2025

Volume	4,053,902
Average Volume	4,286,957
Open	90.01
Previous Close	90.01
Day's Range	88.80 - 91.96
52-Week Range	39.82 - 103.00
Beta	0.51
RSI	40.96
Earnings Date	Aug 27, 2025

About SHA:688578

Shanghai Allist Pharmaceuticals Co., Ltd., a pharmaceutical company, engages in the research and development of tumor-targeted drugs in China. Its lead product is vometinib mesylate tablet for the treatment of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (NSCLC), as well as for treating adult patients with locally advanced or metastatic NSCLC. The company was founded in 2004 and is based in Shanghai, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 1,417
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688578

Financial Performance

In 2024, SHA:688578's revenue was 3.56 billion, an increase of 76.29% compared to the previous year's 2.02 billion. Earnings were 1.43 billion, an increase of 121.97%.